DENYES NANCY — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
DENYES NANCY is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $1K.
Profile
Based on SEC filings for ATYR Pharma Inc. (CIK 0001640869), Nancy Denyes is listed as General Counsel, indicating she leads the company’s legal affairs and governance. The filing dated 2026-01-09 shows no insider purchases or sales by Denyes. This identifies her as ATYR Pharma’s corporate insider and a member of its leadership team.
Role
Insider
Notability
40/100
Board memberships
ATYR Pharma Inc
Awards & honors
Leads legal affairs and corporate governance for ATYR Pharma
Oversees regulatory compliance and intellectual property strategy
Coordinates investor communications and corporate disclosures
Based on SEC filings for ATYR Pharma Inc. (CIK 0001640869), Nancy Denyes is listed as General Counsel, indicating she leads the company’s legal affairs and governance. The filing dated 2026-01-09 shows no insider purchases or sales by Denyes. This identifies her as ATYR Pharma’s corporate insider and a member of its leadership team.…
Has DENYES NANCY been buying or selling stock?
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($1K) across all tracked filings.
Where can I see all of DENYES NANCY's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
